Similar articles

• Time to put boots on the ground: making universal access to MDR-TB treatment a reality.

  Keshavjee S, Farmer PE. Keshavjee S, et al. Int J Tuberc Lung Dis. 2010 Oct;14(10):1222-5. Int J Tuberc Lung Dis. 2010. PMID: 20843411 No abstract available.
• Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.

  Pablos-Mendez A, Gowda DK, Frieden TR. Pablos-Mendez A, et al. Bull World Health Organ. 2002;80(6):489-95; discussion 495-500. Bull World Health Organ. 2002. PMID: 12132008 Free PMC article.
• Multidrug resistant tuberculosis: trends and control.

  Prasad R, Gupta N, Singh M. Prasad R, et al. Indian J Chest Dis Allied Sci. 2014 Oct-Dec;56(4):237-46. Indian J Chest Dis Allied Sci. 2014. PMID: 25962197 Review.
• Limited access to drugs for resistant tuberculosis: a call to action.

  Bélard S, Janssen S, Osbak KK, Adegnika AA, Ondounda M, Grobusch MP. Bélard S, et al. J Public Health (Oxf). 2015 Dec;37(4):691-3. doi: 10.1093/pubmed/fdu101. Epub 2014 Dec 19. J Public Health (Oxf). 2015. PMID: 25527468
• Issues facing TB control (7). Multiple drug-resistant tuberculosis.

  Raviglione MC. Raviglione MC. Scott Med J. 2000 Oct;45(5 Suppl):52-5; discussion 56. doi: 10.1177/00369330000450S124. Scott Med J. 2000. PMID: 11130318 Review. No abstract available.